scholarly journals Unexpected Association of HIV, Hepatitis C Virus Infection, Lymph Node Tuberculosis, and Sickle Cell Disease: A Case Report in a 35-Year-Old Woman from Cameroon

2019 ◽  
Vol 09 (02) ◽  
pp. 21-27
Author(s):  
Hilaire Djantio ◽  
Gilder Tonfack Temgoua ◽  
Vassili Aurel Njami ◽  
Serge Lombat ◽  
Rahim Seid Ndam ◽  
...  
Keyword(s):  
Case Report ◽  
Lymph Node ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Sickle Cell Disease ◽  
Virus Infection ◽  
Sickle Cell ◽  
Hepatitis C Virus Infection ◽  
Cell Disease ◽  
Lymph Node Tuberculosis

scholarly journals Role of autoimmunity in hepatitis c VIRUS infection: a case report and a brief review of literature

2015 ◽  
Vol 8 ◽  
pp. A175
Author(s):  
Fabiana Mascarenhas ◽  
Myrthes Toledo Barros ◽  
Leonardo Mendonça ◽  
Pablo Torres ◽  
Karla Boufleur ◽  
...  
Keyword(s):  
Case Report ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Review Of Literature ◽  
Hepatitis C Virus Infection

Polyarteritis Nodosa Associated With Hepatitis C Virus Infection: A Case Report

2015 ◽  
Vol 110 ◽  
pp. S371
Author(s):  
Freeha Khan ◽  
Tuyyab Hassan ◽  
Sulieman Abdal Raheem ◽  
Annette Kyprianou
Keyword(s):  
Case Report ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Polyarteritis Nodosa ◽  
Hepatitis C Virus Infection

scholarly journals Successful Treatment of Hepatitis C Virus by Ledipasvir/Sofosbuvir in a Cirrhotic Patient with Sickle Cell Disease and Thalassemia Minor

2018 ◽  
Vol 12 (3) ◽  
pp. 629-632 ◽  
Author(s):  
Hassan Al Moussawi ◽  
Abhishek D. Polavarapu ◽  
Divya Asti ◽  
Zainab Awada ◽  
Stephen  Mulrooney
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Sickle Cell Disease ◽  
Sickle Cell ◽  
Cirrhotic Patient ◽  
Cell Disease ◽  
Hcv Treatment ◽  
Direct Acting Antiviral ◽  
Thalassemia Minor ◽  
Direct Acting

Around 8% of patients diagnosed with sickle cell disease (SCD) are hepatitis C virus (HCV) carriers. Previously, HCV treatment was seldom considered in SCD patients, as the ribavirin-induced hemolysis and interferon-induced cytopenias could lead to more profound anemia. Nowadays, several oral direct-acting antiviral drugs have been developed and approved by the FDA for hepatitis C treatment. While direct-acting antivirals mitigate many of these risks, their safety and efficacy in SCD patients remains insufficiently explored. Here, we report on successfully treating HCV with ledipasvir/sofosbuvir in a compensated cirrhotic patient with SCD and thalassemia minor.

scholarly journals Hepatitis C virus infection in a Brazilian population with sickle-cell anemia

2003 ◽  
Vol 36 (3) ◽  
pp. 323-329 ◽  
Author(s):  
M.C.M.R. Torres ◽  
L.M.M.B. Pereira ◽  
R.A.A. Ximenes ◽  
A.S. Araújo ◽  
M. Secaf ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Sickle Cell ◽  
Sickle Cell Anemia ◽  
Brazilian Population ◽  
Hepatitis C Virus Infection
Sign in / Sign up

Export Citation Format

Share Document